Relay Therapeutics, Inc. (RLAY) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $84.02M | -32.4% |
| 2024 | $124.29M | -13.5% |
| 2023 | $143.74M | -5.3% |
| 2022 | $151.79M | -45.8% |
| 2021 | $280.12M | -37.4% |
| 2020 | $447.65M | +967.0% |
| 2019 | $41.95M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $84.02M | -32.4% |
| 2024 | $124.29M | -13.5% |
| 2023 | $143.74M | -5.3% |
| 2022 | $151.79M | -45.8% |
| 2021 | $280.12M | -37.4% |
| 2020 | $447.65M | +967.0% |
| 2019 | $41.95M | — |